Healthpeak Properties Price Target Cut by Citigroup Analysts

Analysts lower price target to $17.50 amid neutral rating for real estate investment trust

Apr. 1, 2026 at 8:54pm

Citigroup analysts have lowered their price target for Healthpeak Properties (NYSE:DOC) from $18.00 to $17.50, while maintaining a 'neutral' rating for the real estate investment trust. The analysts cited ongoing challenges in the healthcare real estate sector as the reason for the reduced price target.

Why it matters

Healthpeak Properties is a major player in the healthcare-focused real estate investment trust (REIT) space, with a diverse portfolio of life science facilities, medical offices, and senior housing communities. Analyst price target adjustments can signal broader market sentiment and influence investor perceptions of the company's growth prospects.

The details

In a research report issued on Wednesday, Citigroup analysts reduced their price target for Healthpeak Properties from $18.00 to $17.50, while reiterating a 'neutral' rating on the stock. The analysts noted ongoing challenges in the healthcare real estate sector, including headwinds from the COVID-19 pandemic, as factors contributing to the lower price target.

  • Citigroup issued the updated research report on Wednesday, April 1, 2026.

The players

Healthpeak Properties

A real estate investment trust (REIT) that specializes in healthcare-related properties, including life science research facilities, medical office buildings, and senior housing communities.

Citigroup

A global financial services company that provides investment banking, securities, asset management, and other financial products and services.

Got photos? Submit your photos here. ›

The takeaway

The price target reduction by Citigroup analysts reflects the ongoing challenges facing the healthcare real estate sector, which could impact Healthpeak Properties' growth and financial performance in the near term. Investors will be closely monitoring the company's ability to navigate these headwinds and maintain its position as a leading player in the healthcare REIT space.